产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | RBE (人肝胆管癌细胞) (STR鉴定正确) |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:2-1:3 |
推荐换液频率 | 2-3次/周 |
背景描述 | RBE细胞是一株人肝胆管癌细胞;据说,RBE细胞可产CEA和CA19-9。 |
年龄(性别) | 女性 |
组织来源 | 肝 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肝胆癌细胞 |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 12 D2S1338 17,24 D3S1358 14,15 D5S818 11,12 D7S820 8,11 D8S1179 13,14 D13S317 9 D16S539 10,11 D18S51 13,15 D19S433 14,15.2 D21S11 29 FGA 19,24 PentaD 12 PentaE 18 TH01 6 TPOX 8 vWA 20 D6S1043 14 D12S391 18 D2S441 10,11 -
STR鉴定图
参考文献
-
Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis (2024-02-28)
作者:Chao Zhang:1.Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, 324 Jingwuwei 7Th Road, Jinan, 250021, Shandong, People's Republic of China. ; 2.Department of Hepatobiliary Surgery, Linyi People's Hospital, Linyi, 276034, Shandong, People's Republic of China. ; Chengkun Qin:1.Department of Hepatobiliary Surgery, Shandong Provincial Hospital, Shandong University, 324 Jingwuwei 7Th Road, Jinan, 250021, Shandong, People's Republic of China. qinchengkun_slyy@163.com. ;
期刊:Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis
DOI:10.1007/s13577-024-01032-7
影响因子 :4.3
引用产品: HCCC-9810 细胞 , HuCC-T1 细胞 , RBE 细胞
-
Circ_0020256 induces fibroblast activation to drive cholangiocarcinoma development via recruitment of EIF4A3 protein to stabilize KLF4 mRNA (2023-05-13)
作者:Zongyan Li:1.Department of Pancreatic Hepatobiliary Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510650, Guangdong Province, P.R. China. ; Zuxiao Chen:1.Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, Guangdong Province, P.R. China. ; Shiying Li:1.Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, Guangdong Province, P.R. China. ; Xiangjun Qian:1.Department of Pancreatic Hepatobiliary Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510650, Guangdong Province, P.R. China. ; Lei Zhang:1.Department of Pancreatic Hepatobiliary Surgery, Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510650, Guangdong Province, P.R. China. ; Guojie Long:1.Department of Pancre
期刊:Circ_0020256 induces fibroblast activation to drive cholangiocarcinoma development via recruitment of EIF4A3 protein to stabilize KLF4 mRNA
DOI:10.1038/s41420-023-01439-5
影响因子 :7.0
引用产品: HCCC-9810 细胞 , RBE 细胞
-
Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma (2023-06-05)
作者:Wei Zhao:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: zhaoweiqdfy@126.com. ; Jing Zhao:1.Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Kun Li:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Yanjiao Hu:1.Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Dongxia Yang:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Bin Tan:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ; Jian Shi:1.Department of Hepatobiliary and Pancreatic Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China. ;
期刊:Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma
DOI:10.1016/j.labinv.2023.100193
影响因子 :5.0
引用产品: RBE 细胞 , HCCC-9810 细胞
-
SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis (2023-03-01)
作者:Fanghua Chen:1.Jinshan Hospital Center for Tumor Diagnosis and Therapy, Jinshan Hospital, Fudan University, Shanghai 201508, China. ; 2.Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai 200032, China. ; Ling Aye:1.Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai 200032, China. ; Lei Yu:1.Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai 200032, China. ; Longzi Liu:1.Department of Digestive Surgery, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Jiangxi 330000, China. ; Yuming Liu:1.Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University, Shanghai 200032, Chi
期刊:SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis
影响因子 :4.7
引用产品: RBE 细胞
-
Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma (2023-05-04)
作者:Zuyi Ma:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. ; Tiange Xie:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. ; Jia Sun:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100005, China. ; Jianchun Yu:1.Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science a
期刊:Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma
DOI:10.1186/s12885-023-10810-9
影响因子 :3.8
引用产品: HuCC-T1 细胞 , RBE 细胞 , CCLP-1 细胞 , huh28 细胞 , QBC939 细胞 , HCCC-9810 细胞
-
Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules (2023-02-16)
作者:Yanfei Chu:1.Clinical Medicine Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Doufei Shi:1.Department of Geriatric Medicine, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Nan Wang:1.Clinical Medicine Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Lebin Ren:1.Clinical Medicine Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Naiguo Liu:1.Clinical Medicine Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Fengai Hu:1.Clinical Medicine Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Wei Meng:1.Clinical Medicine Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, Shandong, People's Republic of China. ; Sung-Jong Hong:1.Department of Medic
期刊:Clonorchis sinensis legumain promotes migration and invasion of cholangiocarcinoma cells via regulating tumor-related molecules
DOI:10.1186/s13071-023-05694-4
影响因子 :3.2
引用产品: RBE 细胞
-
METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10 (2022-12-07)
作者:Jingli Cai:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New Area, Shanghai, China. 417327108@qq.com. ; Zheng Cui:1.Department of Ultrasonic Medicine, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, Shanghai, China. ; Jingyi Zhou:1.Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ; Bosen Zhang:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New Area, Shanghai, China. ; Ruiqi Lu:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, Tongji University School of Medicine, No. 150, Jimo Road, Pudong New Area, Shanghai, China. ; Youcheng Ding:1.Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease,
期刊:METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
DOI:10.1186/s12935-022-02809-2
影响因子 :6.4
引用产品: RBE 细胞 , HCCC-9810 细胞
-
Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340–5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma (2022-12-06)
作者:Jintian Tang:1.Department of Hepatopancreatobiliary, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China. ; Runjuan Tang:1.Rehabilitation Department, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China. ; Peng Gu:1.Interventional Department, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China. ; Jing Han:1.Office of Drug Clinical Trial Institutions, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China. ; Wukui Huang:1.Interventional Department, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China. ; Feng Xue:1.Department of Hepatopancreatobiliary, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China. ;
期刊:Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340–5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma
影响因子 :3.2
引用产品: 人肝内胆管上皮细胞 , RBE 细胞 , HuCC-T1 细胞
-
Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression. (2022-11-04)
作者:Jian Sun:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Menglong Feng:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Huilian Zou:1.Department of Gynaecology and Obstetrics, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Yanping Mao:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. ; Wei Yu:1.Department II of General Surgery, Hanchuan People's Hospital, Hanchuan, Hubei, China. yuwei19811110@163.com. ;
期刊:Circ_0000284 facilitates the growth, metastasis and glycolysis of intrahepatic cholangiocarcinoma through miR-152-3p-mediated PDK1 expression.
影响因子 :2.1
引用产品: RBE 细胞 , HCCC-9810 细胞 , 人肝内胆管上皮细胞
-
LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis (2002-01-20)
作者:Wei Zhao:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. zhaoweiqdfy@126.com. ; Jing Zhao:1.Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, People's Republic of China. ; Xiao Guo:1.Heart Center, Qingdao Fuwai Cardiovascular Hospital, Qingdao, 266034, People's Republic of China. ; Yujie Feng:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. ; Bingyuan Zhang:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. ; Lantian Tian:1.Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266000, People's Republic of China. ;
期刊:LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis
DOI:10.1186/s12885-021-07838-0
影响因子 :3.8
引用产品: HCCC-9810 细胞 , RBE 细胞
-
Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma (2011-00-20)
作者:Xiangyu Zhai:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; 2.Department of General Surgery, Qilu Hospital of Shandong University, Jinan, China. ; Wei Wang:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Yunlong Ma:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Yijia Zeng:1.Radiology Department, Qilu Hospital of Shandong University, Jinan, China. ; Dandan Dou:1.School of Basic Medical Sciences, Shandong University, Jinan, China. ; Haoning Fan:1.College of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China. ; Jianping Song:1.Department of Surgery, School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Xin Yu:1.School of Basic Medical Sciences, Shandong University, Jinan, China. ; Danqing Xin:1.School of Basic Medical Sciences, Shandong
期刊:Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma
影响因子 :5.2
引用产品: HCCC-9810 细胞 , RBE 细胞
-
Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin (2005-08-20)
作者:Qixiang Ma:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Yanyan Feng:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Kaiwen Deng:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Haozhen Shao:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's Republic of China. ; Tongtong Sui:1.School of Life Sciences, Centre For Translational Oncology, Beijing University of Chinese Medicine, 11 Beisanhuandong Road, Chaoyang District, Beijing 100029, People's R
期刊:Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin
影响因子 :3.9
引用产品: HCCC-9810 细胞 , RBE 细胞
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图